Hepatitis C Virus E1 and E2 Proteins Used as Separate Immunogens Induce Neutralizing Antibodies with Additive Properties

Various strategies involving the use of hepatitis C virus (HCV) E1 and E2 envelope glycoproteins as immunogens have been developed for prophylactic vaccination against HCV. However, the ideal mode of processing and presenting these immunogens for effective vaccination has yet to be determined. We us...

Descripción completa

Detalles Bibliográficos
Autores principales: Beaumont, Elodie, Roch, Emmanuelle, Chopin, Lucie, Roingeard, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788456/
https://www.ncbi.nlm.nih.gov/pubmed/26966906
http://dx.doi.org/10.1371/journal.pone.0151626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788456/
https://www.ncbi.nlm.nih.gov/pubmed/26966906
http://dx.doi.org/10.1371/journal.pone.0151626

Ejemplares similares